For families and patients wanting more information about Allo Phase 2 Clinical Trial: LEARN MORE

For symptomatic peri- and post menopausal women interested in information regarding clinical trial to test the safety and efficacy of PhytoSERM, a potential alternative to hormone therapy. LEARN MORE

Center leads all University of Arizona Health Sciences grants for FY20

The Center for Innovation in Brain Science received the largest FY20 grant in the University of Arizona Health Sciences. The $37.5 million grant is one of the largest received by the university and is funding our multi-site Phase II clinical trial of allopregnanalone, a potential regenerative therapy for Alzheimer’s disease.

https://healthsciences.arizona.edu/connect/features/covid-19-partnerships-drive-record-year-research-funding

Leave a Reply

Your email address will not be published.

The Center for Innovation in Brain Science (CIBS) at the University of Arizona is addressing the challenge that, in the 21st century, there is not a single cure for a single neurodegenerative disease and is focused on four age-associated neurodegenerative diseases: Alzheimer’s, Parkinson’s, Multiple Sclerosis and ALS.

© 2021 Center for Innovation Brain Science. University of Arizona Health Sciences.